Figure 2
From: Activation of an endogenous retrovirus-associated long non-coding RNA in human adenocarcinoma
EVADR is robustly expressed in adenocarcinomas. (a) EVADR expression in 25 TCGA cancer types and corresponding normal tissues. Light orange indicates the tumors analyzed and light grey indicates normal samples analyzed. The hashtag (#) indicates that 916 BRCA samples were analyzed. Dark red indicates the number of adenocarcinoma samples in which EVADR expression was detected, while dark grey indicates the number of normal samples in which EVADR was detected. (b) EVADR expression as log2(RPKMS + 1), determined for tumors using TASR. Medians are indicated by red lines, upper and lower quartiles by the boxes, and outliers by blue crosses. COAD, colon adenocarcinoma; LUAD, lung adenocarcinoma; STAD, stomach adenocarcinoma; READ, rectum adenocarcinoma; PAAD, pancreatic adenocarcinoma; BLCA, bladder urothelial carcinoma; PRAD, prostate adenocarcinoma; LUSC, lung squamous cell carcinoma; HNSC, head and neck squamous cell carcinoma; ACC, adrenocortical carcinoma; KIRP, kidney renal papillary cell carcinoma; BRCA, breast invasive carcinoma; LIHC, liver hepatocellular carcinoma; KIRC, kidney renal clear cell carcinoma; UCEC, uterine corpus endometrial carcinoma; CESC, cervical squamous cell carcinoma and endocervical adenocarcinoma; SKCM, skin cutaneous melanoma; LGG, brain lower grade glioma; KICH, kidney chromophobe; OV, ovarian serous cystadenocarcinoma; GBM, glioblastoma multiforme; DLBC, lymphoid neoplasm diffuse large B-cell lymphoma; SARC, sarcoma; THCA, thyroid carcinoma; UCS, uterine carcinosarcoma.